Minerva Neurosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $82.3M | $21.4M | $40.9M | $36.1M | $60.8M | $25.4M | $21.4M | $50.2M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $83.1M | $22.3M | $42.0M | $40.2M | $62.2M | $27.4M | $47.1M | $90.0M |
| Property, Plant & Equipment | $0 | $5.4K | $10.9K | $16.3K | — | — | $16.0K | $33.5K |
| Goodwill | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M | $14.9M |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | $15.2M | $15.2M | $34.2M |
| Total Assets | $98.0M | $37.1M | $56.9M | $55.1M | $77.1M | $57.6M | $77.5M | $139.1M |
| Liabilities | ||||||||
| Accounts Payable | $639.7K | $1.6M | $1.8M | $969.7K | $1.9M | $995.6K | $2.3M | $1.8M |
| Total Current Liabilities | $2.3M | $2.8M | $3.3M | $1.4M | $2.8M | $3.2M | $6.6M | $3.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $233.8M | $62.8M | $85.4M | $75.1M | $69.1M | $5.0M | $49.7M | $48.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-688.8M | $-395.4M | $-396.8M | $-366.8M | $-334.7M | $-284.8M | $-286.7M | $-214.6M |
| Total Stockholders' Equity | $-140.7M | $-25.7M | $-28.5M | $-20.0M | $8.0M | $52.7M | $27.8M | $90.3M |